Recent updates on systemic treatment of atopic dermatitis

Abstract

Atopic dermatitis (AD) is a complex disease with multifactorial pathogenesis and variable clinical presentation. Up to one-fifth of patients with AD develop moderate to severe disease that is often refractory to classical therapies and can compromise quality of life. This review summarizes recent clinical evidence on biological agents and small-molecule immunotherapies for the treatment of AD.

Keywords

• atopic dermatitis
• biologics
• small molecules
• treatment